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but also means losing a highly valued organ that plays an impor-
tant part in sexual activity and – for young women – in child rais-
ing. Sophisticated oncoplastic surgery techniques are now available 
that potentially achieve satisfactory cosmesis; sexual and – proba-
bly much less important but not negligible – lactational capacities 
of the breast, however, are irrevocably lost. Surgery and radiation 
of the axilla, still necessary in many cases, bear a strong risk of 
lymphedema that may lead to considerable disfigurement as well. 
In addition to these harms to femininity, breast cancer therapy ex-
poses many patients to appallingly aversive states that are inade-
quately labeled as nausea and vomiting, and there is a plethora of 
other deleterious side effects, several of them painful and even dis-
abling, e.g. peripheral neuropathy. Some breast cancer patients 
navigate these tribulations with stupefying resilience – many oth-
ers, understandably, are overwhelmed by them. 
This not only burdens the patients themselves but also their 
families. As psycho-oncologists (K.H., U.B.) and patient advocates 
(R.H.), we are sometimes told what it was like to be a child in a 
family affected by breast cancer. Some of the stories that are re-
counted to us are heartbreaking, and they have repercussions 
throughout adult life, like that of a young patient who consulted 
one of us because she tended to totally relinquish her own wishes 
and needs, whereas she anxiously sought to satisfy those of the per-
sons close to her. She reported that her mother had been diagnosed 
with breast cancer when she herself was a schoolchild. She tried 
whatever she could to relieve her mother’s burden and was happy 
when her mother was at home and did not cry. The family did not 
talk about the situation at all. Her father, her little brother, she her-
self and her mother – all had needed help but none of them re-
ceived it. When her mother finally died, her devastated father left 
his adolescent children to return only years later.
Psycho-oncology was still in its infancy when this happened 
some 30 years ago, while it is now firmly established as an integral, 
indispensable part of breast cancer therapy. Gratifyingly, guide-
In public perception, breast cancer seems to increasingly have 
become a manageable disease – to the point that breast cancer pa-
tients are sometimes faced with minimization of their condition, 
expressed in remarks like, ‘Don’t be upset – it’s only breast cancer.’ 
Indeed, prospects have considerably brightened for breast cancer 
patients. Nowadays, the vast majority of them will never develop 
metastatic disease, and even for those who do there is often some 
reasonable hope for many more years of life. Nevertheless, in a re-
cently published large-scale investigation, mental disorders were 
found to be present in 42% of breast cancer patients. No other 
group of cancer patients showed an equally high rate of psycho-
logical morbidity [1]. Why do breast cancer patients experience 
exceptionally high levels of distress, despite a generally favorable 
prognosis?
Even with enormous advances in diagnosis and treatment of 
breast cancer, no affected woman can be sure of permanent cure. 
Disease progression and its dire consequences remain a constant 
threat for decades after primary diagnosis. Further, the treatments 
that are so efficaciously saving lives are at the same time not very 
successful at preserving the patients’ physical, functional, and psy-
chosocial wellbeing; thus, they come at high costs for the patients 
[2]. In particular, breast cancer therapy is a massive attack on a 
woman’s female integrity, affecting nearly all key aspects of femi-
ninity; namely sexuality, child bearing, ability to breastfeed, and 
feminine attraction. Both chemotherapy and endocrine therapy 
have long-lasting or even permanent consequences for sexual func-
tioning [3]. Chemotherapy threatens to destroy a patient’s fertility; 
endocrine therapy deprives her of the actions of estrogens and may 
force her to delay child bearing for as long as 10 years – which 
mostly implies forgoing it. Further, chemotherapy inevitably dam-
ages a woman’s good looks for the better part of a year and be-
reaves her of a part of her body that is precious to most women, her 
hair. A considerable number of breast cancer patients still have to 
undergo mastectomy. This may not only result in disfigurement 
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lines are progressively emerging that set standards for identifica-
tion and treatment of distressed cancer patients, such as the new 
German psycho-oncology guideline that is described in the edito-
rial by Joachim Weis in this issue [4]. Certainly, psycho-oncology 
cannot prevent all heartbreak; however, a recent meta-analysis 
found evidence that psycho-oncologic interventions have sustained 
small-to-medium effects on emotional distress and quality of life in 
cancer patients in general. In highly distressed patients, the effects 
were found to be large [5]. 
In the issue that is accompanied by this editorial, Susanne 
Singer and her colleagues report on breast cancer patients’ fears of 
different treatments as assessed in the large-scale BRENDA II 
study [6]. Tanja Zimmermann looks into the consequences of 
breast cancer for both partners in an intimate relationship and de-
lineates interventions for couples [7]. Valerie A. Jenkins and Lesley 
J. Fallowfield have investigated the reasons why women with breast 
cancer consent or decline to participate in randomized clinical tri-
als – with surprising results [8]. 
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